Right to Cure European Citizens' Initiative registered

The Commission decided today to register a European Citizens' Initiative (ECI) entitled ‘Right to Cure', the EU press service reported. The organisers of the ECI call on the Union “to put public health before private profit and make anti-pandemic vaccines and treatments a global public good, freely accessible to everyone”.

The ECI lists the following objectives: Ensure that intellectual property rights, including patents, do not hamper the accessibility or availability of any future COVID-19 vaccine or treatment; Ensure that EU legislation on data and market exclusivity does not limit the immediate effectiveness of compulsory licenses issued by Member States; Introduce legal obligations for beneficiaries from EU funds to share COVID-19 health technology related knowledge, intellectual property and/or data in a technology or patent pool; Introduce legal obligations for beneficiaries from EU funds regarding transparency on public contributions, production costs, as well as accessibility and affordability clauses combined with non-exclusive licenses.

The Commission considers that the ECI is legally admissible, as it meets the necessary conditions, and therefore decided to register it. The Commission has not analysed the substance of the ECI at this stage.

Following today's registration of the ECI, the organisers can start, within the next 6 months, a 1-year process of collection of signatures of support. Should the ECI receive 1 million statements of support within 1 year from at least 7 different Member States, the Commission will have to react within 6 months. The Commission could decide either to follow the request, or not, and in both instances would be required to explain its reasoning.

Similar articles